CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
5.03
+0.35 (7.48%)
At close: Mar 9, 2026, 4:00 PM EDT
5.00
-0.03 (-0.60%)
After-hours: Mar 9, 2026, 7:03 PM EDT
CytomX Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 852 | 81 | 104 | 106 | 283 | 303 | |
| Market Cap Growth | 1233.74% | -22.37% | -1.80% | -62.58% | -6.69% | -19.81% | |
| Enterprise Value | 714 | -26 | -75 | -70 | 69 | 7 | |
| Last Close Price | 5.03 | 1.03 | 1.55 | 1.60 | 4.33 | 6.55 | |
| PE Ratio | 21.00 | 2.53 | - | - | - | - | |
| Forward PE | - | - | 16.30 | - | - | - | |
| PS Ratio | 7.50 | 0.58 | 1.03 | 1.99 | 7.57 | 4.43 | |
| PB Ratio | 7.73 | -176.77 | -2.19 | -1.23 | -615.53 | -38.95 | |
| P/TBV Ratio | 8.04 | - | - | - | - | - | |
| P/FCF Ratio | - | - | - | - | - | 102.63 | |
| P/OCF Ratio | - | - | - | - | - | 57.57 | |
| EV/Sales Ratio | 6.29 | - | - | - | 1.84 | 0.11 | |
| EV/FCF Ratio | - | - | - | - | - | 2.48 | |
| Debt / Equity Ratio | 0.05 | -20.58 | -0.29 | -0.21 | -47.22 | -3.20 | |
| Debt / EBITDA Ratio | 0.20 | 0.31 | - | - | - | - | |
| Debt / FCF Ratio | - | - | - | - | - | 8.43 | |
| Net Debt / Equity Ratio | -1.28 | 200.08 | 3.38 | 2.05 | 617.76 | 37.46 | |
| Net Debt / EBITDA Ratio | -5.63 | -3.41 | 37.26 | 1.92 | 2.50 | 3.74 | |
| Net Debt / FCF Ratio | 1.91 | 1.05 | 2.82 | 1.56 | 2.35 | -98.73 | |
| Asset Turnover | 0.77 | 0.86 | 0.44 | 0.18 | 0.11 | 0.20 | |
| Quick Ratio | 3.54 | 1.21 | 1.14 | 1.51 | 3.93 | 4.65 | |
| Current Ratio | 3.64 | 1.25 | 1.17 | 1.55 | 3.99 | 4.76 | |
| Return on Equity (ROE) | 66.76% | - | - | - | - | -299.13% | |
| Return on Assets (ROA) | 9.78% | 9.69% | -1.75% | -19.54% | -20.78% | -14.38% | |
| Return on Capital Employed (ROCE) | 19.80% | 71.90% | -14.10% | -86.70% | -44.40% | -27.70% | |
| Earnings Yield | 3.29% | 39.54% | -0.55% | -93.93% | -41.01% | -21.41% | |
| FCF Yield | -8.49% | -107.36% | -54.78% | -106.42% | -42.70% | 0.97% | |
| Buyback Yield / Dilution | -41.04% | -14.82% | -12.27% | -2.48% | -39.01% | -1.79% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.